The Investors Centre Reviewed: Does Funding Your Own Broker Accounts Actually Help?
A British comparison site that pays to open the accounts it writes about. Admirable, expensive, and not automatically better than the alternative. We spent some time with it.
Financial comparison sites are a genre with a credibility problem, and everybody working in it knows precisely why. The economics reward volume and affiliate placement rather than accuracy. A site can be commercially successful while being close to useless, and several are.
So when an operation claims to do the opposite, to spend money rather than collect it in order to produce a ranking, it is worth checking whether the claim survives contact with the actual output. That is what this review is.
What exactly is being claimed?
Straightforwardly, that The Investors Centre funds live accounts with its own money to test UK trading platforms instead of building rankings from providers’ published fee schedules. It also states that it funds its own testing rather than ranking platforms by affiliate commission, and that its market research is compiled from FCA filings and brokers’ annual disclosures. Three claims, all falsifiable, which is a promising start. A claim you cannot check is not really a claim.
Does the output look like something that was tested?
Largely, yes. The distinguishing feature is the presence of information you can only obtain by using a platform. Withdrawal timings, expressed in days rather than in the vague language of terms and conditions. Inactivity fees, with the point at which they start applying. What currency conversion actually cost on a specific order, in pounds, rather than as a percentage you have to model yourself.
Those details are tedious to gather and difficult to fabricate convincingly. A site working purely from pricing pages cannot write them, so it does not, and the absence is noticeable once you know to look.
The cost tables also do something that affiliate comparisons rarely bother with: they model a specific trading pattern rather than presenting fees in the abstract. That is more useful, because fees in the abstract are almost meaningless: the cheapest platform for somebody buying UK shares twice a year is not the cheapest for somebody trading US equities weekly.
Is the data work checkable?
This is the part that impressed me more, partly because it is easier to verify. The trading statistics cite FCA filings and brokers’ own annual disclosures, and when I followed a couple of the figures back they resolved to real documents saying what the site said they said.
That sounds like a low bar. In financial content it is not. An enormous proportion of quoted statistics trace back, through several intervening articles, to a press release, and the number has usually drifted along the way. Anything sourced from regulatory filings occupies a different category.
Where is it weaker?
Several places, and it would be a poor review that skipped them.
Coverage is narrower than the large affiliate operations manage. That is an unavoidable consequence of the model: funded accounts cost money, money is finite, so fewer platforms get tested. If you want every provider available in Britain in a single table, this is not the widest list you will find.
Real-money testing also has limits that enthusiasm for the method tends to gloss over. A funded account tells you what happened to one account, over one period, with one pattern of trading, in one set of market conditions. It is far better evidence than a pricing page, but it is not a controlled experiment, and it cannot tell you what a platform will be like for you specifically.
What does funding the accounts not fix?
The site is also UK-focused, which is a strength for a British reader and a limitation for anyone else.
And there is a structural point worth making about any comparison site, this one included: it is still a business with commercial relationships in the sector it covers. Funding your own testing removes one conflict. It does not remove all of them, and no reader should treat a single source as final on a decision involving several thousand pounds.
How does the testing work in practice?
As far as can be reconstructed from what is published: an account is opened the way an ordinary retail customer would open it, funded with the site’s own money, and then used. Trades are placed, positions held, statements kept, and a withdrawal requested at the end. The costs recorded are the ones that appeared on statements rather than the ones described in the terms.
That produces a specific kind of finding. It is very good on anything that happens to a real account – conversion applied at a real exchange rate, the gap between a quoted spread and a filled price, how long money takes to arrive back in a bank account. It is weaker on anything requiring scale, such as how a platform behaves under heavy load, or how its pricing compares across thousands of orders.
Honest testing of that second category needs institutional data that nobody at retail level has. Any site claiming otherwise is overstating what a handful of funded accounts can show.
Is the writing trying to sell you something?
Less than the sector norm, though not zero. Pages are structured as comparisons rather than recommendations, and the language around leveraged products is noticeably more cautious than the industry standard – loss disclosures are quoted rather than buried, and the material repeatedly notes that most retail traders lose money.
There is still an implicit commercial interest in you eventually opening an account somewhere, as with any comparison site. The relevant question is not whether commercial interest exists but whether it is distorting the content, and on the evidence of the cost tables it does not appear to be doing so aggressively.
What about the statistics work specifically?
It is the strongest part of the site and arguably deserves separating from the comparison function entirely. Compiling figures from FCA filings and brokers’ annual disclosures is genuine primary work, and the sort of thing normally done by trade bodies or regulators rather than consumer sites.
The figures carry named filings and dates, so a reader can check them against the source documents without trusting the site at all. If you have no interest in platform comparison at all, that section still has value.
There is a ceiling on how good this can get, though. Any statistic derived from disclosures inherits every definitional choice the disclosing firm made. Firms report on their own terms, active client means different things in different sets of accounts, and financial years do not line up, so anything aggregated across firms is welding together periods that never matched. The figures are as good as the filings, which is considerably better than most alternatives and a long way short of definitive.
How does it handle what it cannot test?
Reasonably transparently. Areas that cannot be assessed from a funded retail account – institutional execution quality, order routing, internal risk practices – are largely left alone rather than filled with speculation. That is the right call, and a discipline several better-resourced sites do not manage. The corresponding weakness is that a reader wanting an opinion on everything will find gaps. Whether that is a flaw or a virtue depends on your view of confident opinions offered without evidence.
How does it compare with the affiliate model?
| Affiliate comparison site | Real-money testing site | |
| Cost of producing a review | Very low | High |
| Breadth of platform coverage | Wide | Narrower |
| Fee accuracy | As published by the provider | As actually charged |
| Ranking influenced by commission | Frequently | States otherwise |
| Withdrawal and exit information | Usually absent | Usually present |
| Useful for building a shortlist | Yes | Yes |
| Useful immediately before depositing | Partly | More so |
| Should be your only source | No | No |
Neither model is worthless. They answer slightly different questions, and the second is more expensive to run.
Who should actually use it?
If you are at the stage of funding an account and want to know what it will cost you in practice, this is the more useful of the two models, and the cost detail is where the value sits.
If you are at the earlier stage of working out which platforms even exist for what you want to do, a broad affiliate list will get you there faster and the ordering will not matter much at that point.
If you are researching market data rather than platforms, the FCA-derived statistics are the strongest thing on the site and stand on their own.
What is the verdict?
The methodology claim holds up, which is more than can be said for a good deal of the sector, and the data sourcing is genuinely better than the norm. The limitations are real: narrower coverage, and a testing method that is stronger than a pricing page without being scientific.
Read it for costs and for the regulatory data. Cross-reference it, as you should cross-reference anything. And apply the same question to it that it invites you to apply elsewhere: where did these numbers come from? In this case the answer appears to be a funded account and a filing, which is the right answer.
